HCC occurred in 1.27% of patients with PBC, which is lower than the recommended threshold for cost-effective surveillance.

Of the 510,000 PBC patients, 240,000 will experience cholestatic pruritus. The FDA granted linerixibat orphan drug designation in the treatment of PBC and associated cholestatic pruritus in 2019.

Most people have never heard of primary biliary cholangitis (PBC), but the progressive, rare cholestatic liver disease can cause uncomfortable and even life-altering symptoms, and if left ...

1 While there is currently no cure for PBC, treatment focuses on slowing the progression of the disease. One of the key challenges is that PBC is often underreported due to its subtle onset and ...

It has been filed for the second-line treatment of adult PBC patients, without cirrhosis or with compensated cirrhosis, who do not respond or are intolerant to ursodeoxycholic acid (UDCA).

Ipsen Biopharmaceuticals Canada Inc. today announced Health Canada has issued a Notice of Compliance with Conditions (NOC/c) ...

There isn’t a cure for PBC, but the right treatment plan can slow its progress and boost your quality of life as you live with it.

in reducing pruritus in people with primary biliary cholangitis (PBC) – – Additional presentations will showcase the potential for maintained virologic response following treatment with ...

Primary biliary cholangitis (PBC) is an autoimmune disorder that leads to the destruction of bile ducts within the liver. As more bile ducts become lost and damaged, bile acids build up within the ...

Gilead Sciences, Inc. (Nasdaq:GILD) today announced new research to be presented at the European Association for the Study of ...